Skip to main content
. 2017 Sep 27;102(12):4496–4505. doi: 10.1210/jc.2017-01179

Table 1.

Baseline Characteristics of Daily D Health Study Participants (n = 604)

600 IU (n = 207) 1000 IU (n = 190) 2000 IU (n = 207)
Age, y 11.7 (1.4) 11.7 (1.3) 11.7 (1.5)
Female sex, no. (%) 109 (52.7) 89 (46.8) 109 (52.7)
Race/ethnicity, no. (%)
 White 92 (44.4) 81 (42.6) 71 (34.3)
 Black 23 (11.1) 28 (14.7) 34 (16.4)
 Hispanic or Latino 42 (20.3) 43 (22.6) 50 (24.2)
 Asian 20 (9.7) 17 (9.0) 16 (7.7)
 Multiracial or other 30 (14.5) 21 (11.1) 36 (17.4)
Constitutive skin colora 33.1 (25.1) 30.9 (25.6) 29.7 (25.8)
Facultative skin colora 13.2 (23.8) 11.2 (24.3) 9.8 (24.6)
Height, cm 149.5 (11.3) 150.9 (11.2) 151.1 (10.8)
Weight, kg 48.7 (16.0) 50.6 (15.9) 50.0 (15.8)
Body mass index, kg/m2 21.3 (4.6) 21.8 (5.0) 21.6 (5.0)
Body mass index, z score 0.78 (1.05) 0.82 (1.14) 0.79 (1.09)
Weight status, no. (%)
 Normal 107 (51.7) 103 (54.2) 114 (55.1)
 Overweightb 51 (24.6) 33 (17.4) 39 (18.8)
 Obeseb 49 (23.7) 54 (28.4) 54 (26.1)
Puberty, no. (%) 67 (32.4) 66 (34.7) 78 (37.7)
Household income, no. (%)
 <$30,000 92 (44.4) 94 (49.5) 103 (49.8)
 ≥$30,000 102 (49.3) 87 (45.8) 88 (42.5)
 Missing 13 (6.3) 9 (4.7) 16 (7.7)
Free or reduced-price lunch eligible, no. (%) 135 (65.2) 131 (68.9) 146 (70.5)
Dietary vitamin D, IU/d 123.1 (80.9) 141.0 (109.2) 127.6 (87.1)
Vitamin D or multivitamin in past month, no. (%) 17 (8.2) 27 (14.2) 27 (13.0)
Serum 25(OH)D status,c no. (%)
 <12 ng/mL 16 (7.7) 7 (3.7) 10 (4.8)
 12−19 ng/mL 70 (33.8) 65 (34.2) 71 (34.3)
 20−29 ng/mL 92 (44.4) 104 (54.7) 100 (48.3)
 ≥30 ng/mL 29 (14.0) 14 (7.4) 26 (12.6)

Data are presented as mean (standard deviation) unless otherwise indicated.

a

Skin color was classified using individual typology angle: very light > 55 > light > 41 > intermediate > 28 > tanned > 10 > brown > −30 > dark (26).

b

Overweight was defined as 85th to 94th BMI percentile; obese was defined as ≥95th BMI percentile.

c

Serum 25(OH)D status was defined as follows: <12 ng/mL = severe deficiency; 12 to 19 ng/mL = deficiency; 20 to 29 ng/mL = insufficiency; ≥30 ng/mL = sufficiency.